Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancerYasuhisa Hasegawa, Tomoko Furukawa, Makoto Adachi et al.|Oral Oncology|2006Cited by 34
Cell-cycle distribution and Thymidilate Synthatase (TS) expression correlate with 5-FU resistance in head and neck carcinoma cells.Kei Ijichi, Shingo Murakami, Makoto Adachi et al.|PubMed|2014Cited by 22
Etodolac improves 5-FU sensitivity of head and neck cancer cells through inhibition of thymidylate synthase.Shogo Murata, Iwai Tohnai, Makoto Adachi et al.|PubMed|2011Cited by 14
Human MLH1 status can potentially predict cisplatin sensitivity but not microsatellite instability in head and neck squamous cell carcinoma cellsMakoto Adachi, Nobutake Kanematsu, Kei Ijichi et al.|Experimental and Therapeutic Medicine|2009Cited by 11
Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cellsKei Ijichi, Kanji Ishizaki, Yoshihiro Yasui et al.|Cancer Chemotherapy and Pharmacology|2007Cited by 11